• Roivant's move to go public reveals just how much its drug strategy has changed

    14 days ago - By MedCity News

    Founded by former hedge fund manager Vivek Ramawamy, Roivant Sciences set out to redefine drug development by acquiring overlooked drugs and advancing their development. The merger deal that will take it public reveals how much new technology changed the company's vision and its strategy.
    Read more ...